MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanism
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanism
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 22, Issue 8, Pages 3887-3898
Publisher
Wiley
Online
2018-05-15
DOI
10.1111/jcmm.13662
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MUC1-C drives MYC in multiple myeloma
- (2016) Ashujit Tagde et al. BLOOD
- Influence of survivin-targeted therapy on chemosensitivity in the treatment of acute myeloid leukemia
- (2015) Jingcao Huang et al. CANCER LETTERS
- Clinical aspects for survivin: a crucial molecule for targeting drug-resistant cancers
- (2015) Neha Singh et al. DRUG DISCOVERY TODAY
- Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway
- (2015) Yi Zhang et al. Molecular Cancer
- Characterization of the MUC1-C Cytoplasmic Domain as a Cancer Target
- (2015) Deepak Raina et al. PLoS One
- Survivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1
- (2014) S Fukuda et al. LEUKEMIA
- MUC1-C oncoprotein promotes FLT3 receptor activation in acute myeloid leukemia cells
- (2013) S. Liu et al. BLOOD
- MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells
- (2013) D. Stroopinsky et al. CANCER RESEARCH
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- Survivin is highly expressed in CD34+38- leukemic stem/progenitor cells and predicts poor clinical outcomes in AML
- (2012) B. Z. Carter et al. BLOOD
- MUC1-C Oncoprotein Induces TCF7L2 Transcription Factor Activation and Promotes Cyclin D1 Expression in Human Breast Cancer Cells
- (2012) Hasan Rajabi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cooperative Interaction between the MUC1-C Oncoprotein and the Rab31 GTPase in Estrogen Receptor-Positive Breast Cancer Cells
- (2012) Caining Jin et al. PLoS One
- Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia
- (2011) E. Park et al. BLOOD
- MUC1-C oncoprotein suppresses reactive oxygen species-induced terminal differentiation of acute myelogenous leukemia cells
- (2011) L. Yin et al. BLOOD
- Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH
- (2011) L. Yin et al. BLOOD
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- The Wnt/ -Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
- (2010) Y. Wang et al. SCIENCE
- Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells
- (2010) Y. Saito et al. Science Translational Medicine
- Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3
- (2009) S. Fukuda et al. BLOOD
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases
- (2008) Szabolcs Fatrai et al. EXPERIMENTAL HEMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started